Lomefloxacin and temafloxacin: Two new fluoroquinolone antimicrobials

Keyphrases

• Antimicrobial 100%
• Lomefloxacin 100%
• Fluoroquinolones 100%
• Recurrent Urinary Tract Infections (rUTIs) 22%
• Ciprofloxacin 22%
• Non-gonococcal Urethritis 22%
• Lower Respiratory Tract Infection 22%
• Drug Interactions 22%
• Elimination Half-life 11%
• Surgical Procedures 11%
• Gastrointestinal Problems 11%
• Adverse Effects 11%
• Infection-bacterial 11%
• Headache 11%
• Bacterial Infection 11%
• Antipseudomonal 11%
• Safety Self-efficacy 11%
• Cystitis 11%
• New Antimicrobials 11%
• Moderate Activity 11%
• Gram-positive Organisms 11%
• Anaerobic Organism 11%
• Infection Infection 11%
• Oral Fluoroquinolones 11%
• Mechanism of Action 11%
• Interaction Profile 11%
• Gastrointestinal Upset 11%
• Urinary Tract Infection 11%
• Cervicitis 11%
• Chronic Bacterial Prostatitis 11%
• Enterobacteriaceae 11%
• Antimicrobial Spectrum 11%
• Chronic Bronchitis 11%
• Oral Absorption 11%
• Increased Activity 11%
• Clinical Efficacy 11%
• Drug Dosage 11%
• Urinary Tract 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Temafloxacin 100%
• Lomefloxacin 100%
• Antiinfective Agent 100%
• Quinolone Derivative 100%
• Urinary Tract Infection 33%
• Gastrointestinal Symptom 22%
• Drug Interaction 22%
• Lower Respiratory Tract Infection 22%
• Ciprofloxacin 22%
• Uterine Cervicitis 11%
• Chronic Bronchitis 11%
• Enterobacteriaceae 11%
• Clinical Pharmacokinetics 11%
• Gram Positive Bacterium 11%
• Anaerobe 11%
• Infection 11%
• Prostatitis 11%
• Adverse Event 11%
• Bacterial Infection 11%
• Cystitis 11%
• Gonococcal Urethritis 11%
• Headache 11%
• Elimination 11%
• Streptococcus 11%
• Nonspecific Urethritis 11%